Empagliflozin is a medication used in the management and treatment of type 2 diabetes mellitus. It is in the sodium-glucose co-transporter (SGLT-2) class of medication for diabetes. This activity describes the indications, action, and contraindications for empagliflozin as a valuable agent in treating type 2 diabetes mellitus. This activity will highlight the mechanism of action, dosing, monitoring pertinent for members of the interprofessional team in the management of patients with type 2 diabetes.

**Objectives:**
- Identify indications for initiating empagliflozin therapy.
- Outline the contraindications for empagliflozin therapy.
- Describe common and uncommon adverse effects of empagliflozin therapy.
- Review interprofessional strategies that will improve outcomes when prescribing/ordering empagliflozin therapy.